Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedResults were posted on 2026-08-28 with the study marked as Completed. The update adds result sections for ORR, DOR, PFS, and irPFS, and provides links to the Study Protocol and Statistical Analysis Plan, along with the Results First Posted timeline.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows the full Study Details for NCT03457948, including enrollment and study dates, sponsor and collaborators, and locations. It also adds detailed Study Record Dates metadata (First Submitted, First Posted, Last Update, Study Record Updates) to document the record history.SummaryDifference60%

- Check36 days agoChange DetectedThe page's revision metadata was updated from v3.6.4 to v3.6.5, indicating an incremental version update.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a deployment of updates to the study details page. This reflects a newer build of the page rather than a modification to the study data itself.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study page now shows 'Results Submitted' instead of 'No Results Posted', indicating that results are in the submission process or awaiting posting.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision on the page updated to v3.6.3 from v3.6.2, indicating a small site release; no visible changes to the study details are expected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.